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Carcinogenesis bioassays ofblocky (nonfibrous) tremolite and amosite asbestos alkne
or in combination with the intestinal carcinogen 1,2-dimethylhydrazine dihydrochloride
(DMH) were conducted with male and female Fischer 344 rats. The minerals were
administered at a concentration of 1% in pelleted diet for the entire lifetime of the rats
starting with the dams of the test animals. One group of amosite rats also received
chrysotile asbestos via gavage during lactation. Group sizes varied from 100 to 250
animals.
The offspring from mothers exposed to tremolite or amosite asbestos were smaller at
weaning than those from untreated mothers and remained smaller throughout their life.
The administration ofdimethylhydrazine (DMH) did notaffectbodyweight gain, either in
amosite-exposed or nonexposed animals. Survival was comparable in the tremolite and
control groups. The amosite-exposed rats showed enhanced survival compared to the
untreated controls. DMH exposure reduced survival by approximately one year, al-
though the amosite plus DMH groups survived slightly better than the DMH alone
groups.
No toxicity or increase in neoplasia was observed in the tremolite-exposed rats com-
pared to the controls. Significant increases (p < 0.05) in the rates of C-cell carcinomas of
the thyroid and monocytic (mononuclear cell) leukemia in male rats were observed in
amosite-exposed groups. However, the biological significance ofthe C-cell carcinomas in
relationtoamosite asbestos exposure is discounted because ofalackofsignificance when
C-cell adenomas and carcinomas were combined and the positive effect was not observed
in the amosite plus preweaning gavage group. The biological significance ofan increased
incidence of mononuclear cell leukemia is questionable, because of a lack of statistical
significance in the amosite group when evaluated using life table analysis, lack of
significance when compared to the tremolite control group, and the fact that no toxic or
neoplastic lesions were observed in the target organs, i.e., gastrointestinal tract and
mesothelium.
DMH caused a high rate of(62-74%1) ofintestinal neoplasia in amosite and nonamosite-
exposed groups. Neither an enhanced carcinogenic nor protective effect was demon-
strated by exposure to amosite asbestos.
Introduction
In November 1973 the National Institute of
Environmental Health Sciences and the Environ-
mental Protection Agency cosponsored a sympo-
sium on the possible biological effects ofingested
asbestos. (1). This conference concluded that a
paucity of definitive data existed concerning the
*The National 'lbxicology Program, National Institute of
Environmental Health Sciences, P.O. Box 12233, Research
Triangle Park, NC 27709.
tHazelton Laboratories America, Inc., 9200 Leesburg Pike,
Vienna, VA 22180.
effects of ingested asbestos and that specific re-
search was needed.
A subcommittee of the DHEW Committee to
Coordinate Ibxicology and Related Programs was
establishedto reviewexistingdata and toprepare
adraftresearch protocol thatwouldbe responsive
to the possible public health implication of in-
gested asbestos. This protocol was widely distrib-
uted for comment within and outside the govern-
ment and a public meeting ofthe subcommittee
was held on February 11, 1975. On the basis of
the comments received, a revised final protocol
was developed which called for the use of long-McCONNELL ET AL.
term animal toxicology studies to evaluate the
ingestion of several minerals for carcinogenic ef-
fect. As aresult, the National Toxicology Program
has investigated the carcinogenic potential ofthe
ingestion of chrysotile asbestos in hamsters and
rats, amosite asbestos in hamsters and rats, cro-
Table 1. Fiber characteristics ofamosite asbestos.
Fiber characteristics
Surface area, m2/g 4.13
Density, g/cm3 3.35 ± 0.026 SD
Measurements, transmission electron microscopy
Fiber count/g 0.3466 x 1010
Median length (>m) 4.37
Range oflength, gm 0.85 - 995
Median diameter, gm 0.72
Range ofdiameter, gm 0.064 - 12.4
Median fiber aspect ratio (lld) 6.4248
Table 2. Chemical-instrumental analysis ofamosite
asbestos.
Content, wt-%
A1203 0.42
CaO 0.48
FeO 34.61
Fe2O3 2.24
MgO 6.22
K20 0.30
SiO2 50.36
Na2O 0.03
MnO 2.66
Cr2O3 0.03
NiO 0.01
CO2 0.88
H20- 0.15
H20+ 2.30
Benzene extracted organics 0.021
cidolite asbestos in rats and tremolite in rats. All
of the studies were to encompass the lifetime of
the animal, including exposure ofthe dams from
which the test animals were derived.
Crystalline tremolite (not actually in asbestos
fiber) was chosen for this study because up to 20
years ago it was a common contaminant of talc
which was used in foods and pharmaceuticals.
The grinding of tremolite in preparation for its
intended use may result in the production of
fibers which have the morphology of asbestos
minerals. Stanton et al. (2), in reviewing intra-
pleural mineral deposition studies, speculated
thatthe asbestos mineral hazard question may be
directly related to fiber size in contrast to chemi-
cal composition. Therefore, the study of crystal-
line tremolite was deemed appropriate because of
its past widespread exposure and the fact that it
assumes fiber characteristics when ground in the
processing oftalc.
This report represents the results ofthose stud-
ies undertaken to determine the effects oftremo-
lite or amosite asbestos in the diet fed to Fischer
344 rats. In addition, the study was designed to
determine ifthe feeding ofamosite asbestos modi-
fied the response of a known intestinal carcino-
gen, 1,2-dimethlhydrazine dihydrochloride
(DMH). Reports on chrysotile and crocidolite as-
bestos will be reported later.
Materials and Methods
Test Materials
Asbestos is a general term applied to certain
natural silicates when they appear in a fibrous
TAble 3. Particle size distribution ofamosite asbestos by particle number: SEM.
Length interval, gm
0-1.99 2-3.99 4-5.99 6-7.99 8-9.99 10-19.99 20-39.99
Amosite mean width, gm 0.28 0.38 0.45 0.45 0.48 0.52 0.51
Amosite particles per interval 57 126 88 78 52 181 184
Tbtal amosite particles, % 5.6 12.3 8.6 7.6 5.1 17.7 18.0
Cumulative % amosite 5.6 17.9 26.5 34.1 39.2 56.9 74.9
Amosite, vol-%a - 0.1 0.3 0.4 0.4 2.4 5.0
Cumulative volume-% amosite - 0.1 0.4 0.8 1.2 3.6 8.6
Number ofother particles 11 8 1 0 1 1 0
Amosite particles per
length interval by aspect ratio, %
1:1-2.9:1 12 0 0 0 0 0 0
3:1-4.9:1 34 10 6 5 2 0 0
5:1-9.9:1 43 52 23 14 4 1 1
10:1-19.9:1 11 34 52 38 40 21 1
20:1-49.9:1 0 4 18 41 54 64 30
50:1-99.9:1 0 0 1 2 0 12 55
100:1-199:1 0 0 0 0 0 2 12
200:1-499:1 0 4 0 0 0 0 1
>500:1 0 0 0 0 0 0 0
aCalculated from particle number data, assuming rectangular cross section with third dimension equal to 1/2 measured width.
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form. Amosite is a fibrous member ofthe amphi-
bole mineral group, its chemical structure is
(Fe2+Mg)7Si8O22 (OH)2. Mineral and fiber charac-
teristics ofamosite are shown in Tables 1-3.
The amosite sample identified as S-33 was pur-
chased by the Bureau of Mines from the Atlas
Asbestos Company, Montreal, Quebec, Canada.
This material is from a mine in the areaknown as
Penge, inthelfansvaal, Republic ofSouth Africa.
Not a proper mineral name, amosite is a term
used to describe the material from asbestos mines
Table 4. Fiber characteristics and
chemical-instrumental analysis oftremolite.
Fiber characteristics
Surface area, m2/g
Density, g/cm3
Analyses, wt-%
A1203
CaO
Fe2O3
MgO
K20
SiO2
Na2O
MnO
Li20
SnO
SrO
Bi2O3
C02
H20-
H20+
Benzene-extracted organics
5.2 ± 0.5
2.91 ± 0.01 SD
1.57
11.26
0.27
26.71
0.18
54.00
0.80
0.03
0.05
0.02
0.01
0.03
0.01
0.78
0.24
3.73
0.003
in South Africa. Tb develop homogeneity of the
samplethe amosite wasprocessedby asingle pass
through an airjet mill.
The temolite sample used in this study was
obtained from a single lense from the Governeur
Talc Company, Governeur, NY. This 1200-lb lense
was taken from the 500 ft level, American vein,
No. 4 footwall stope, lower portion ofthe footwall
bedding. The lense was crushed in a Denver Jaw
Crusher and then to minus 14 mesh in a roll
crusher. This material was then wheeler-milled
at204°C andbagged in 50-lb Kraftbags. The final
particle size was nominal minus 325 mesh. Tb
develop homogeneity of the sample, approxi-
mately 960 lb tremolite was blended in a 10 ft3 V-
type blender. Mineral and fiber characteristics of
tremolite are shown in Tables 4 and 5.
After final blending the samples were weighed
to 25 0.5 lb and placed in fiberboard drums.
These drums were shipped to a special warehouse
at Research lTiangle Park, NC. Each drum re-
ceived a color marking unique to the mineral
type. Homogeneity ofthe samples was verified by
fluorescent X-ray spectrography for samples col-
lected from six randomly selected drums. No sig-
nificant differences were detected.
The homogeneity ofthe samples and the physi-
cal and chemical properties ofthe materials were
characterized by the Bureau of Mines, U.S. De-
partment ofthe Interior (Supt. ofDocuments No.
I 28.23:8452) and by the Fine Particle Laborato-
ries, Illinois Institute ofTechnology Research In-
Table 5. Particle size distribution for tremolite by particle number: SEM.
Length interval, gm
0-0.99 1-1.99 2-2.99 3-3.99 4-4.99 5-5.99 6-6.99 7-7.99 8-8.99 9-9.99 >10
Mean width, gm 0.48 0.88 0.97 1.51 2.05 2.19 2.79 3.29 2.96 3.13 5.22
Number ofparticles per interval 59 291 194 106 53 40 31 19 9 13 58
% ofall particles per interval 6.8 33.4 22.3 12.2 6.1 4.6 3.6 2.2 1.0 1.4 6.4
Cumulative % ofall particles 6.8 40.2 62.5 74.7 80.8 85.4 89.0 91.2 92.2 93.6 100
TIemolite particles per interval 34 197 128 83 38 27 23 15 9 12 49
% oftremolite particles 5.5 32.0 20.8 13.5 6.2 4.4 3.7 2.4 1.5 2.0 8.0
Cumulative % tremolite 5.5 37.5 58.3 71.8 78.0 82.4 86.1 88.5 9.0 92.0 100
lTlc-serpentine particles per interval 9 72 53 19 11 9 8 4 0 1 7
Other particles per interval 16 22 10 4 2 4 0 0 0 0 2
Tremolite particles
perlength interval
by aspect ratio, %a,i
1:1-2.9:1 100 92 75 67 76 67 65 66 67 30 35
3:1-4.9:1 0 8 22 29 18 30 30 20 22 35 37
5:1-9.9:1 0 0 3 4 6 3 5 7 11 35 18
10:1-19:1 0 0 0 0 0 0 0 7 0 0 4
20:1-49:1 0 0 0 0 0 0 0 0 0 0 4
50:1-99:1 0 0 0 0 0 0 0 0 0 0 0
100:1-199:1 0 0 0 0 0 0 0 0 0 0 2
aData for aspect ratio obtained from a second set ofmeasurements.
b"Ibtal particles = 871, total tremolite = 615, total talc-serpentine = 193, and total other = 63.
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stitute, Chicago, IL (Special Report and Adden-
dum on project L6085, contract N01-ES-5-3157).
Copies ofthese reports are availableuponrequest
from the National Toxicology Program.
Test Diets
The feedused was NIH-31 open formula rodent
diet prepared by Zeigler Brothers, Inc., Gardner,
PA. Tremolite or amosite asbestos was incorpora-
ted to a level of 1% by weight into the test diet.
All feed was pelleted with a Sprout-Waldron pel-
leter; the pellets were ofoval configuration, 3/8 in.
by 3/4 in. in size. Pelleted feedwaspackaged in 25-
lb aliquots in standard paper feedbags which
were color coded to minimize the occurrence of
feeding errors at the test laboratory.
Each lot ofblended feed was analyzed for tre-
molite or amosite asbestos concentrations, pesti-
cide contamination and nutrient content.
1% Chrysotile (MediumRange) Gavage.* The
required amount ofchrysotile (medium range), a
gray powder with lumps, was weighed on a Met-
tler balance and placed in a beaker. Sterile water
(for injection) was added to obtain the desired
concentration andthe suspension was thenmixed
in a magnetic stirrer for a short period of time.
The suspension was administered by gavage, at a
dose level of 0.47 mg/g of body weight, to the
amosite and preweaning gavage (PWG) animals
from birth to weaning (21 days).
Source and Specifications ofTest
Animals
Parental Generation (F,). Weanling Fischer
344 (caesarean-derived) rats, which were barrier
sustained and specific pathogen-free, were pur-
chased from Charles River Breeding Laborato-
ries, Inc., Wilmington, MA. These animals consti-
tuted the Fo generation.
On arrival, animals were taken directly to the
quarantine area and acclimated to laboratory
conditions for approximately 2 weeks. At 24 hr
after the animals arrived, eight animals of each
sex were selected, sacrificed, and pathogen bur-
den was determined for each animal. Pathogens
examined for included ectoparasites, intestinal
parasites, and bacteria. Serological tests were
conducted for viruses. After approximately 2
months of quarantine the rats, both males and
females, were randomized and divided into test
groups by a computerized randomization process
and placed on the appropriate designated diets.
*Animals were to receive 1% amosite, but were inadver-
tently gavaged with 1% chrysotile.
After at least 7 days exposure to the appropri-
ate diets, the rats were placed in breeding cages
(one male to two females). During the breeding
period, the rats continuedtobe fedthe designated
diets; 20days later (onthe average), femaleswere
separated and housed individually in polyearbo-
nate cages (Hazleton Systems, Aberdeen, MD).
Males were removed from the breeding cagesand
re-housed two per cage.
Filial Generation (F'). The Fo females were
allowed to deliver their F1 litters naturally, and
these were reduced to no more than eight pups
(four/sex ifpossible) perlitter. Atbirth,thelitters
from the Fo dams within the control and treated
groups were assigned randomly to the corre-
sponding lifetime feeding phase groups such that
birth dates were equally distributed. All pups
assigned to the amosite and preweaning gavage
(PWG) groups were exposed to the PWG phase of
the study to assure exposure to asbestos from
birth to weaning.
At 21 days after birth, the pups were weaned
and given a temporary number, then selected,
using a random number table, to be placed in
their respective groups for the lifetime feeding
study. Litters in which only one sex was present
were excluded from those animals to be selected.
The extra weanlings were discarded.
At 8 weeks ofage, 1,2-dimethylhydrazine dihy-
drochloride (DMH) was administered by gavage
to a control group and an amosite group every 14
days for a total offive doses. Males received 7.5
mg/kg, and females 15.0 mg/kg, based on a pre-
vious pilot study (3) which showed that these
doses produced an approximate incidence of 15%
intestinal neoplasia. Concentrations of DMH in
the dosing solutions were determined within one
hour prior to dosing and following dosing. The
results of these determinations showed that the
proper concentration ofDMH was present in the
dosing solution and had not deteriorated during
dosing.
Animal Maintenance
The control and mineral exposed rats were
placed in separate rooms with monitored temper-
ature and humidity, and a controlled light cycle
(12 hr light/12 hr dark). Temperature was main-
tained at 74 + 4°F and humidity at 50% + 10%.
The rats were housed threeper cage in polycarbo-
nate cages coveredwith nonwovenpolyesterfilter
sheets and stored on Enviro-racks. Racks and
filters were changed approximately once every 2
weeks. Cages and bedding were replaced twice
perweek. Control andtreated diets andtap water
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via automatic waterers were available ad libi-
tum. Two water samples were collected and sub-
mitted for asbestos analysis. Stainless steel feed
containers were changed once every 2 weeks.
The incoming air in the animal rooms was
filtered to remove particulate matter. Ten to fif-
teen changes ofroom air per hour were provided.
Prior to initiation ofthe study, air samples were
collected and analyzed for baseline asbestos de-
terminations. Additional samplings were col-
lected approximately every 6 months for analysis
to assure personnel safety.
Other measures used for personnel protection
included the wearing of fully protective disposa-
ble suits, gloves, boots and bouffant caps and the
use of a dust/mist respirator mask. Personnel
leaving the animal rooms were required to take
showers. In addition, physical examinations, in-
cludingpulmonary function tests and chestradio-
graphs, were conducted at the initiation of the
study, yearly thereafter, and at the end of the
study.
Clinical Examinations and Pathology
Observations and Records. All animals were
observed twice daily for moribund condition and
mortality. Recorded weekly were individual body
weights; signs of toxicity or pharmacologic ef-
fects; incidence, size and location ofpalpable tis-
sue masses or nodules; and food consumption per
cage.
Sacrifice andGross Pathology. Animals were
sacrificed when exhibiting any one ofthese condi-
tions: palpable masses within the abdominal cav-
ity (excluding retainedtestes); masses protruding
from the rectum; rectal discharge of bright red
fluid (an indication ofthe presence of a bleeding
colonic or rectal neoplasm); large ulcerated
masses in the area of the ears or on side of face
(Zymbal gland tumors); large subcutaneous
masses which have been ulcerated or infected;
masseswhichinterferewithbreathing andeating
orwhich severelyhamperlocomotion; huge tissue
masses (>10 cm); central nervous system signs
accompanied by weight loss (head tilt, circling
incoordination, ataxia, paralysis); severe weight
loss or emaciation; or comatose or very weak.
When the remaining animals ofeither the con-
trol and DMH or the corresponding amosite and
DMH group of either sex was reduced to 10% of
those starting the study, both groups within that
sex were killed. When survival or untreated con-
trol or amosite or amosite and PWG group of
either sex reached 10%, all remaining animals of
these groups within that sex were killed. The
tremolite-exposed groups were handled similarly.
Animals were killed by exsanguination under
sodium pentobarbital anesthesia (Nembutal, Ab-
bott Laboratories, Inc., North Chicago, IL, or
Diabutal, Diamond Laboratories Inc., Des
Moines, IO). Final body weights were recorded
and necropsies performed which included these
additional procedures: blood smears taken from
animals sacrificed in extremis or terminally sacri-
ficed, touch preparations made from any enlarged
spleen or lymphoid organ.
Since the gastrointestinal tract was considered
as the target organ prior to the study, it was
handled in a manner slightly different from that
in standard rodent lifetime bioassays. Prior to
placement in fixative, the entire esophagus was
opened and examined. The stomach and cecum
were opened and pinned with the exterior surface
adjacent to paper; 2-cm lengths ofduodenum and
ileum and two portions ofjejunum were placed
unopened in fixative. The remaining small intes-
tine was opened and washed gently with saline
and the mucosal surface was then examined care-
fully using transillumination on a radiograph
viewingbox. Suspect lesions were processed sepa-
rately and identified individually as to location.
Likewise, the entire colon with anus was opened,
examined, and placed on cardboard (serosal sur-
face down) prior to fixation. The size and location
of masses were recorded. Masses greater than 1
mm in diameter were removed as separate speci-
mens for processing. After fixation and prior to
embedding, the colon was "carpet-rolled" starting
at the proximal end, with the mucosal surface
inward.
All tissues were fixed in 10% neutral buffered
formalin, sectioned, and stained with hematoxy-
lin and eosin. Tissues/organs examined micro-
scopically were: tissue masses, the above-men-
tioned portions of gastrointestinal tract,
mesenteric, celiac, iliocolonic, renal, iliac, mandi-
bular, cervical, pancreatic and bronchial lymph
nodes, mammary gland, salivary gland, thigh
muscle, bone marrow (sternum), nasal cavity
with turbinates, larynx, trachea, lungs and bron-
chi, heart, thyroid, parathyroid, liver, pancreas,
spleen, kidneys, adrenal glands, urinary bladder,
seminal vesicles/prostate, testes/epididymus, ova-
ries/uterus, brain, pituitary gland, eyes and spi-
nal cord.
Data Recording and Statistical
Methods
The individual animal pathology data on this
experiment were recorded in the computerized
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carcinogenesis bioassay data system. The data
elements include descriptive information on the
chemicals, animals, experimental design, clinical
observations, survival, and individual pathologic
results.
Probabilities ofsurvival were estimated by the
product-limit procedure ofKaplan and Meier (4).
Animals were statistically censored as ofthe time
that they died of other than natural causes or
were missing; animals dying from natural causes
were not statistically censored. Differences in sur-
vival were evaluated by Cox's (5) life table
method.
The incidence of neoplastic or nonneoplastic
lesions is given as the ratio of the number of
animals bearing such lesions at a specific ana-
tomic site (numerator) to the number ofanimals
in which that site was examinedo(denominator).
In most instances, the denominators included
only those animals for which that site was exam-
ined histologically. However, when macroscopic
examination was required to detect lesions (e.g.,
skin ormammarytumors) priortohistologic sam-
pling, or when lesions could have appeared at
multiple sites (e.g., leukemia), the denominators
consist ofthe numbers ofanimals necropsied.
For the statistical analyses oftumor incidence
data, two methods of adjusting for intercurrent
mortality were employed. Each used the classical
methods of combining contingency tables devel-
oped by Mantel and Haenszel (6). The first
method of analysis assumed that all tumors of a
given type were fatal; i.e., they caused the death
of the animal, either directly or indirectly. Ac-
cording to this approach, the proportions of tu-
mor-bearing animals in the treated and control
groups were compared at each point in time at
which an animal died with a particular tumor.
The denominators of these proportions were the
total number of animals at risk in each group.
These results were then combined by the Mantel-
Haenszel methods to obtain anoverallprobability
(p) value. This method of adjusting for intercur-
rent mortality is Cox's life table method (5).
The second method ofanalysis assumedthat all
tumors ofa give type were "incidental"; i.e., they
were merely observed at autopsy in animal dying
ofanunrelated cause. Accordingtothisapproach,
the proportions ofmale and female rats found to
have tumors in treated and control groups were
compared in each of five time intervals: 0-60
weeks, 61-86 weeks, 87-112 weeks, 113-126
weeks and beyond 126 weeks. The denominators
ofthese proportions were the number of animals
actually autopsied during the time interval. The
individual time interval comparisons were then
combined by the previously described methods to
obtain a single overall result (7). For comparisons
involving groups receiving DMH (which showed
markedly reduced survival), somewhat shorter
time intervals were utilized for the incidental
tumor test: 0-52 weeks, 53-78 weeks, 79-92
weeks, 93-116 weeks (males), 93-102 weeks (fe-
males), beyond 116weeks (males) andbeyond 102
weeks (females).
Inaddition tothesetests, one otherset ofstatis-
tical analyses was carried out for each primary
tumor: the Fisher exact test based on the overall
proportion of tumor-bearing animals (8). All re-
ported p values are one-sided. Except where
noted, the three alternative analyses gave simi-
lar results.
Results
Establishment ofTest Groups
The experiment was designed to evaluate the
effects of orally ingested tremolite or amosite
asbestos during the entire life of the animal,
starting from the time the rats were able to eat
solid food. For this reason, the mated female rats
had been on the test diets for approximately 12
weeks when the first litters were born. To mini-
mize the chance that the mothers would reject or
cannibalize their young, the litters were not han-
dled during lactation, except for the group receiv-
ing asbestos via preweaning gavage.
Litter size and survivability of offspring were
unaffectedby the presence ofamosite in the diets.
The average numberoflivefetusesborntotremo-
lite-exposed dams was 7.6 versus 7.8 for the con-
trol groups. The average number of live fetuses
born to amosite-exposed dams was 8.5 versus 7.7
for the control groups. Significant mortality was
induced in those pups which received the pre-
weaning asbestos gavage (PWG). The average
size ofthe litters inthis group was 3.4 atweaning
compared to 7.5 in the non-PWG amosite group.
The average weight at birth of the tremolite-
exposed pups was 4.7 g versus 4.8 g for the con-
trols. The average weight at birth ofthe amosite-
exposed pups was 4.7 g versus 4.8 g for the
controls. The tremolite-exposed offspring were
slightly smaller at weaning, 22.8 g versus 26.3 g
(control). The amosite-exposedoffspringwere also
slightly smaller at weaning, 23.2 g versus 27.4 g
(control).
A summary of groups, number of animals and
diets for the filial (F1) animals is presented in
Table 6.
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Table 6. Summary ofdistribution and diets: a lifetime
feeding study oftremolite or amosite asbestos in rats.
No. ofanimals DMH, mg/kga
Test group Male Female % ofdiet Male Female
Control 118 118 0
Tremolite 250 250 1
Control 117 117 0 - -
DMH 125 125 0 7.5 15.0
Amosite 250 250 1 - -
Amosite + DMH 175 175 1 7.5 15.0
Amosite + PWGb 100 100 1 - -
aGavage with 1,2-dimethylhydrazine dihydrochloride.
bAnimal was inadvertently gavaged during preweaning
with intermediate (medium)-range chrysotile instead ofamo-
site.
Clinical Signs
The incidence of clinical signs occurred at es-
sentially comparable frequencies throughout the
study groups except those thatreceived DMH (see
below). No distinct signs ofcompound effect were
noted in any ofthe tremolite- or amosite-treated
animals during the first 52 weeks ofstudy. As the
study proceeded, the incidence of clinical signs
increased among all the groups. At intervals
where there were a large number of moribund
sacrificed animals in any one particular group,
the clinical signs most frequently observed were
supportive of the conditions for moribund sacri-
fice previously outlined in the Methods section. A
comparison of clinical signs observed during the
same selected intervals among all the groups
revealed a larger number of palpable abdominal
masses, tissue masses, and central nervous sys-
tem signs, a well as red discharge and protruding
masses from the rectum in the DMH and amosite
and DMH groups. These findings were presum-
ably due to the administration ofDMH since they
were not clinically observed with any frequency
inany ofthe tremolite- oramosite-treated groups.
Body Weight and Food Consumption
Mean body weights were analyzed at selected
intervals: birth, 3, 8, 11, 15, 24, 33, and 60 weeks
forthe males, andbirth, 3, 8, 11, 16, 27, 48 and 60
weeks for the females by the method of Rao (9).
The data revealed a 13% depressed mean body
weight gain at weaning in both sexes of the tre-
molite groups and 15% in the amosite groups
compared to the controls. The depressed weight
gain in the tremolite- and amosite-exposed rats
was more apparent at 8 weeks of age (tremo-
lite:33% for males and 17% for females; amosite:
37% for males and 25% for females). Weight gain
then paralleled the controls (except for DMH-
exposed rats) for the remainder of the study but
the mineral-exposed rats remained smaller
throughout the study. Both male and female
DMH-exposed groups gained less than their re-
spective controls.
In the tremolite-exposed males and females,
the average weekly food consumption was 97%
that ofthe untreated controls. In the DMH, amo-
site, amosite and DMH, and amosite and PWG
males, the mean weekly food consumption was
102%, 102%, 105%, and 107%, respectively, com-
pared to the untreated control group and 98%,
101%, 105%, and 108% that of the untreated
control for comparable groups offemales.
Survival
Survival data of intervals prior to the final
sacrifice of a group are summarized in Table 7.
There were no significant differences in survival
between the tremolite-exposed and control
groups. Survival of males and females was ap-
proximately equal until 112 weeks, after which
the femalestended to live longer. When compared
to the survival rates of the untreated control
group, the amosite male survival at 118 weeks
was higher, while amosite and PWG male sur-
vival was somewhat less. In female rats, the amo-
site group survival was better than the untreated
controls, while the amosite and PWG group was
about the same. The survival of both groups of
DMH-exposed rats was considerably less thanthe
untreated controls. The amosite plus DMH group
was comparable to the DMH alone group.
Pathology
There were no apparent treatment related neo-
plasms in the digestive tract of the tremolite,
amosite, or amosite PWG groups (Tables 8 and 9).
Also, no specific type was increased, either at a
particular location (e.g., cecum) or in the stom-
ach, small or large intestine as a whole. In addi-
tion, the incidences of non-neoplastic diseases of
the gastrointestinal tract such as enteritis, diver-
ticulitis, ulceration or inflammation in general
were comparable in the control and tremolite- or
amosite-exposed rate (Tables 10 and 11).
There were no organs/tissues in the tremolite-
exposed rats which showed an increased rate of
neoplasia compared to the control groups. Organs
which showed an increase in neoplasms in the
amosite or amosite PWG groups compared to the
control group were the thyroid and hematopoeitic
system. The results are as follows.
Thyroid. Table 12 summarizes the incidence
33Table 7. Survival ofF344 rats in lifetime oral asbestos study at various time points.
Males Females
Age, No. alive/ No. alive/
Group weeks total no. Survival, % total no. Survival, %
Control 106 98/118 83 97/118 82
120 70/118 59 71/118 60
146 6/118 5 20/118 17
148 - - 14/118 12
Themolite 106 206/250 82 207/247 84
120 150/250 60 144/247 58
146 36/250 14 33/246 13
148 - - 22/246 9
Control 106 95/117 81 92/117 79
118 71/117 61 62/117 53
142 7/117 6 20/116 17
146 - - 10/116 9
DMH 106 27/125 22 15/125 12
118 16/125 13 - -
142 - -
146 - - - -
1% Amosite 106 221/250 88 202/246 82
118 117/250 71 162/246 66
142 35/249 14 43/245 18
146 - - 28/245 11
1% Amosite + DMH 106 46/175 26 32/174 18
118 26/175 15 - -
142 - -
146 - - - -
1% Amosite + PWG 106 77/100 77 86/100 86
118 52/100 52 56/100 56
142 6/100 6 15/100 15
146 - - 9/100 9
of thyroid C-cell proliferative lesions. A signifi-
cantly increased incidence of C-cell carcinoma
wasfoundinamosite-treated male rats (p < 0.05).
This effect was not observed in amosite PWG
male rats. Furthermore, the overall incidence of
C-cell tumors (adenomas and/or carcinomas) was
comparable between control and treated groups.
C-cell hyperplasia was equivocally increased in
amosite and amosite PWG female groups.
Hematopoietic System. A significantly in-
creased incidence of mononuclear cell leukemia
occurred in amosite (p < 0.05) and amosite PWG
(p < 0.01) male rats (Table 13). However, neither
group was significant when compared to the tre-
molite control group (39%). This increased inci-
dence was not observed in amosite-exposed fe-
males.
Miscellaneous Neoplasms
Occasionally a somewhat higher or lower rate
ofcommonly occurring neoplasms were observed
in amosite treated groups. A statistically signifi-
cant (p < 0.05) decrease in the rate ofneoplasia
wasobserved inthepancreas (Islet cell adenoma),
adrenal medulla (pheochromacytoma), thyroid
(follicular cell carcinoma) and preputial gland in
at least one group of amosite-exposed rats com-
pared to the controls. Similar observations were
not observed in the tremolite-exposed groups.
Nonneoplastic Findings
Aplethora ofincidental lesions ofagingFischer
344 rats was found in all groups. Statistical anal-
yses showed no obvious correlation between the
incidence of specific lesion types and the type of
treatment. Nonneoplastic lesions that were ob-
served in more than 5% ofthe rats in any ofthe
experimental groups are as follows: skin: epider-
mal inclusion cyst; lung: chronic inflammation
(peribronchiolar and perivascular lymphoid cuff-
ing); spleen: fibrosis, hemosiderosis, extramedul-
lary hematopoeisis, lymphoid atrophy; lymph
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Table 8. Number oftremolite-exposed F344 rats with primary epithelial neoplasms ofthe alimentary tract.
Malesa Femalesa
Control Tremolite Control Tremolite
Animals examined 118 250 118 250
Total alimentary 8(7) 12(5) 3(3) 7(3)
Oral/pharynx
Papilloma 1(1) 1(0) 0(0) 1(0)
Carcinoma 3(3) 1(0) 2(2) 5(2)
Esophagus
Total gastrointestinal 4(3) 9(3) 1(1) 1(0)
Total stomach 3(3) 2(1) 0(0) 0(0)
Nonglandular
Papilloma 2(2) 1(0)
Carcinoma 1(1) 1(0)
Glandular
Polyp
Carcinoma
Tbtal small intestine 0(0) 3(1) 0(0) 0(0)
Polyp 1(0) 1(1)
Adca inpolyp"
Carcinoma 2(1)
Total large intestine 1(1) 4(2) 0(0) 0(0)
Cecum
Polyp 1(0)
Adca in polypb
Carcinoma
Colon
Polyp 1(1) 1(0)
Adca in polypb
Carcinoma 2(1)
aValues in parentheses arepercentages.
bAdenocarcinoma arising in m uspolyp.
nodes (various): lymphoid orreticulum cellhyper-
plasia, lymph-angiectasis, hemorrhage, pigmen-
tation, chronic inflammation; heart: chronic in-
flammation; liver: degeneration, necrosis, fatty
metamorphosis, toxic hepatitis (associated with
leukemia), granuloma, angiectasis, pigmenta-
tion, focal cellular change; bile duct (extrahe-
patic): chronic inflammation, mucosal hyperpla-
sia, cysts, fibrosis; pancreas (exocrine): atrophy,
hyperplasia, ectopia; pancreas (endocrine): hyper-
plasia; kidney: chronic progressive nephropathy,
cysts, pigmentation; pituitary gland: cysts, an-
giectasis, hyperplasia; adrenal (cortex): fatty me-
tamorphosis, hyperplasia; adrenal (medulla): hy-
perplasia; thyroid: follicular cysts, C-cell
hyperplasia; parathyroid: hyperplasia; testes:
seminiferous degeneration, interstitial cell hy-
perplasia; prostate: abscess, chronic inflamma-
tion, glandular hyperplasia; seminal vesicles:
cysts; ovary: follicular and parovarian cysts;
uterus: hydrometra, endometrial cyst; mammary
gland: cystic ducts, glandular hyperplasia, galac-
tocele; mesentery: chronic inflammation; eye: cat-
aract, hemorrhage, inflammation, retinal de-
generation: zymbal gland: cystic ducts; bone:
osteopetrosis, exostoses, marrow hyperplasia. Ali-
mentary tract nonneoplastic lesions are noted in
Tables 10 and 11.
1, 2-Dimethylhydrazine
Dihydrochloride-freated Groups
Two groups of male and female rats were ex-
posed to 1, 2-dimethylhydrazine dihydrochloride
(DMH) by gavage at levels of7.5 mg/kg for males
and 15.0 mg/kgfor females, biweekly for atotal of
five doses. One group served as apositive carcino-
gen control and the other received amosite from
weaning throughout life.
Exposure ofrats to DMH or DMH with amosite
was associated with a dramatically increased in-
cidence ofneoplasms ofthe intestinal tract, Zym-
bal's gland, andliverofmale andfemale rats, and
kidney in female rats. It is also noteworthy that
survival in the DMH groups was shortened due to
the presence ofthese neoplasms.
Table 9 summarizes the numbers of rats with
primary epithelial neoplasms in the gastrointes-
tinal tractby specific site andclassification. Intes-
tinal neoplasms, particularly the adenomatous
polyps, were often multiple within a given ani-
mal.
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Table 9. Number ofamosite-exposed F344 rats with primary epithelial neoplasms ofthe gastrointestinal tract.
Untreated
controla
M F
Animals examined 117
Tbtal gastrointestinal 4(4)
lbtal stomach 1(1)
lbtal small intestine 3(3)
Duodenum
Carcinoma
Adca in polypb
Adenomatous polyp
Jejunum
Carcinoma 2(2)
Adca inpolypb
Adenomatous polyp
Ileum
Carcinoma
Adca in polypb
Adenomatous polyp 1(1)
Tbtal large intestine 0(0)
Cecum
Carcinoma
Adca in polypb
Adenomatous polyp
Tbtal colon O(o)
Ascending colon
Carcinoma
Adca in polypb
Adenomatous polyp
Thansverse colon
Carcinoma
Adca in polypb
Adenomatous polyp
Descending colon
Carcinoma
Adca in polypb
Adenomatous polyp
aValues in parentheses are percentages.
bAdenocarcinoma arising in adenomatous polyp.
117
2(2)
1(1)
0(0)
Amositea
M F
249 250
7(3) 4(2)
2(1) 1(0)
2(1) 3(1)
1(0)
1(0)
1(1) 3(1)
1(1) 3(1)
Amosite PWG'
M F
100 100
3(3) 3(3)
0(0) 0(0)
1(1) 1(1)
1(1)
1(0)
2(1)
0(0)
0(0)
2(2)
1(1)
2(2)
1(1)
1(1) 2(2)
1(0)
1(1)
1(1)
1(1)
2(1) 1(1)
The incidence ofgastrointestinal neoplasia was
dramatically increased with DMH treatment.
However, the incidence appeared to be essentially
comparable between groups receiving DMH alone
and those receiving DMH with amosite. Further-
more, the number of animals with tumors either
inthe small intestine or inthe large intestine was
also essentially comparable between DMH alone
and DMH with amosite. There was no difference
in the time to tumor between the groups.
Evaluation ofthe incidence ofthe three catego-
ries ofintestinal neoplasia (carcinoma, adenocar-
cinoma arising in an adenomatous polyp, and
adenomatous polyp) by site (Table 14) reveals an
increased incidence of duodenal carcinoma (p <
0.05) in the DMH with amosite-treated females,
compared to female rats receiving DMH alone. In
thejejunum, however, this incidence is reversed,
with more carcinomas occurring in the female
group receiving DMH alone.
In the large intestine the frequency of carci-
noma arising in an adenomatous polyp and ade-
nomatous polyps was greatest in the descending
colon. In the cecum, the incidence of carcinoma
was less in the DMH with amosite-treated group
than those treated with DMH alone, in male rats.
This effect was not observed in the female group.
The appearance of carcinomas in the ascending
colon was somewhat greater in DMH with amo-
site-treated males than in males receiving DMH
alone. Adenocarcinoma arising in adenomatous
polyp occurred more frequently in the transverse
colon of male and female rats receiving DMH
with amosite compared to rats receiving DMH
alone.
Kidney Neoplasms
Almost without exception, the renal masses
associated with DMH treatment were malignant
36EFFECTS IN RATS OFDIETARY EXPOSURE TO ASBESTOS
lible 10. Incidence ofnonneoplastic lesions in the alimentary tract ofF344 rats exposed to 1% tremolite in the diet.a
Malesb Femalesb
Control Tremolite Control Tremolite
Animals examined 118 250 118 250
Palate/tongue
Inflammation 0(0) 0(0) 0(0) 4(2)
Necrosis 0(0) 0(0) 0(0) 1(0)
Hyperkeratosis 0(0) 1(0) 0(0) 2(1)
Acanthosis 1(1) 3(1) 1(1) 1(0)
Esophagus
Inflammation 1(1) 0(0) 0(0) 1(0)
Necrosis 2(2) 1(0) 0(0) 0(0)
Hyperkeratosis 9(8) 18(7) 3(3) 4(2)
Acanthosis 1(1) 0(0) 0(0) 1(0)
Stomach-nonglandular
Mineralization 13(11) 5(2) 4(3) 2(1)
Inflammation, chronic 19(16) 29(12) 25(21) 38(15)
Ulceration 10(8) 17(7) 9(8) 11(4)
Necrosis 20(17) 46(18) 17(4) 31(12)
Hyperplasia 3(3) 1(0) 0(0) 2(1)
Hyperkeratosis 18(15) 34(14) 15(13) 29(12)
Acanthosis 26(22) 54(22) 23(19) 45(18)
Stomach-glandular
Hyperplasia 7(6) 1(0) 3(3) 0(0)
Small intestine
Inflammation 0(0) 2(1) 0(0) 1(0)
Necrosis 2(2) 0(0) 1(1) 3(1)
Ulceration 0(0) 1(0) 0(0) 0(0)
Colon
Parasitism 5(4) 32(13) 5(4) 3(1)
Inflammation 0(0) 5(2) 3(3) 0(0)
Necrosis 0(0) 3(1) 1(1) 1(0)
Hyperplasia 0(0) 1(0) 0(0) 1(0)
Cecum
Parasitism 9(8) 2(1) 2(2) 1(0)
Inflammation 1(1) 2(1) 4(4) 1(0)
Necrosis 1(1) 4(2) 1(1) 3(1)
Hyperplasia 0(0) 0(0) 0(0) 1(0)
Rectum
Necrosis 0(0) 1(0) 0(0) 0(0)
Anus (no lesions)
aIncidence ofnonneoplastic lesions that occur with a frequency of 1% or more in at least one group.
bValues in parentheses are percentages.
mesenchymal ormixedmalignanttumors. Purely
mesenchymal growths were classified according
to their morphology (i. e., fibrosarcoma, undiffer-
entiated sarcoma). Those having epithelial ele-
ments or epithelial-like elements were classified
asmixedmalignant tumors. Inearly stages, these
neoplasms appeared as interstitial sclerosing
growths near the inner cortex. Collagen forma-
tion was accompanied by proliferating, baso-
philic, primitive-appearing cells. Epithelial ele-
ments consisted ofglands, ductlike structures or
poorly differentiated solid tubules. The growths
were often massive but rarely metastasized.
Table 15 summarizes the incidence of kidney
tumors in control and DMH-treated groups. The
high incidence of renal neoplasms was confined
almost exclusively to treated female rats receiv-
ing either DMH alone or DMH with amosite (p <
0.01). The incidence rates for the two treated
female groups was the same. Renal neoplasms
occurred infrequently in male rats.
Zymbal Gland Neoplasms
Carcinoma was the most commonly observed
neoplasm in Zymbal's gland. These neoplasms
were composed ofproliferating eosinophilic to ba-
sophilic squamous epithelial cells which formed
thick fingers of tissue, masses of keratin and
nests of sequestered cells. Some had sebaceous
features with formation of sebum. Infiltration of
adjacent tissues was not uncommon; however,
metastases were rare. Table 16 summarizes the
number of control and DMH-treated rats with
Zymbal's gland neoplasms.
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Table 11. Incidence ofnonneoplastic lesions in the alimentary tract ofF344 rats exposed to amosite asbestos.a
Controlb
M F
Tongue, number examined
Esophagus, number examined
Hyperkeratosis
Stomach, nonglandular, number examined
Mineralization
Inflammation, chronic
Ulceration
Necrosis
Hyperkeratosis
Acanthosis
Muscle degeneration
Stomach, glandular, number examined
Hyperplasia
Duodenum, number examined
Jejunum, number examined
Ileum, number examined
Colon, number examined
Parasitism
Cecum, number examined
Rectum, number examined
Anus, number examined
117
115
12(10)
117
9(8)
21(18)
13(11)
23(20)
22(19)
31(26)
8(7)
117
6(5)
117
117
117
117
4(3)
117
117
117
117
117
7(6)
117
3(3)
21(18)
4(3)
13(11)
24(21)
26(22)
2(2)
117
2(2)
117
117
117
117
2(2)
117
117
117
Amositeb
M F
249
249
4(2)
249
2(1)
56(22)
25(10)
41(16)
41(16)
62(25)
3(1)
249
0(0)
249
249
249
249
17(7)
249
249
249
250
246
7(3)
250
2(1)
60(24)
30(12)
37(15)
56(22)
72(29)
3(1)
250
1(0)
249
249
249
250
6(2)
250
250
250
Amosite PWGb,C
M F
100 100
100 100
12(12) 6(6)
100 100
1(1) 0(0)
17(17) 18(18)
7(7) 10(10)
15(15) 11(11)
16(16) 17(17)
21(21) 23(23)
0(0) 0(0)
100 100
0(0) 0(0)
100 100
100 100
100 100
100 100
4(4) 8(8)
100 100
100 100
100 100
aIncidence ofnonneoplastic lesions that occur with a frequency of1% or more in at least one group.
bValues in parentheses are percentages.
CPWG = preweaning gavage.
Table 12. Number ofF344 rats with thyroid C-cell proliferative lesions.
Controla Amositea Amosite PWGa
M F M F M F
Animals examined 117 116 246 247 100 100
Total C-cell tumors 27(23) 24(21) 76(31) 65(26) 25(25) 29(29)
C-cell adenoma 16(14) 14(12) 26(11) 37(15) 11(11) 15(15)
C-cell carcinoma 11(9) 10(9) 50*(20) 29(12) 14(14) 14(14)
C-cell hyperplasia 21(18) 22(19) 58(24) 71(29) 23(23) 26(26)
aValues in parentheses are percentages.
*p < 0.05 vs. controls (incidental tumor and Fisher exact tests).
Table 13. Number ofamosite-exposed F344 rats with mononuclearleukemia.
Untreated
control Amosite AmositePWG
M F M F M F
Animals examined 117 117 249 250 100 100
Mononuclear cell leukemiaa 38(32) 40(34) 106*(42) 82(33) 49t(49) 34(34)
'Values in parentheses are percentages.
*p < 0.05 vs. controls (incidental tumor and Fisher's exact test).
tp < 0.01 vs. controls.
Approximately one quarter ofall rats receiving
DMH alone or DMH with amosite developedZym-
bal's gland neoplasms (p < 0.01), while in control
animals the occurrence was low (1-3%). The inci-
dence appeared essentially comparable between
the two DMH-treated groups.
Liver Neoplasms
The classification of hepatocellular proliferative
lesions was based on the ILAR Monograph (10).
Table 17 summarizes the number of control or
DMH-treated rats withneoplastic nodules orhep-
atocellular carcinoma.
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Table 14. Number ofDMH-exposed F344 rats with primary epithelial neoplasms ofthe gastrointestinal tract.
Untreated DMH positive DMH with
controla controla amositea
M F M F M F
Animals examined 117 117 125 124 173 175
Ibtal gastrointestinal 4(4) 2(2) 92(74) 77(62) 118(68) 114(65)
Total stomach 1(1) 1(1) 3(2) 4(3) 2(1) 1(1)
Total small intestine 3(3) 0(0) 18(14) 14(11) 19(11) 24(14)
Duodenum
Carcinoma 0(0) 0(0) 11(9) 3(2) 13(8) 19(11)
Adca in polypb
Adenomatous polyp
Jejunum
Carcinoma 2(2) 0(0) 2(1) 11(9) 3(2) 2(1)
Adca in polypb 1(1)
Adenomatous polyp 1(1)
Ileum
Carcinoma 2(1)
Adca in polypb 1(1)
Adenomatous polyp 1(1)
Tbtal large intestine 0(0) 1(1) 81(65) 70(56) 110(64) 101(58)
Cecum
Carcinoma 16(13) 7(6) 6(3) 6(3)
Adca in polypb
Adenomatous polyp 2(1)
Tbtal colon
Ascending colon
Carcinoma 10(8) 10(8) 20(12) 14(8)
Adca in polypb 2(1) 4(3) 3(2) 7(4)
Adenomatous polyp 5(4) 7(6) 5(3) 8(5)
Transverse colon
Carcinoma 1(1) 2(1) 2(1)
Adca in polypb 8(6) 9(7) 21(12) 20(11)
Adenomatous polyp 8(6) 6(5) 22(13) 22(13)
Descending colon
Carcinoma (1) 3(2) 2(1)
Adca in polypb 20(16) 15(12) 25(14) 22(13)
Adenomatous polyp 1(1) 34(27) 27(22) 40(23) 31(18)
Colon (other)c
Carcinoma 4(3) 2(1) 2(1)
Adca in polypb
Adenomatous polyp 1(1) 1(1) 1(1)
aValues in parentheses are percentages.
bAdenocarcinoma arising in adenomatous polyp.
cColon (other) = site not identified.
Table 15. Number ofDMH-exposed F344 rats with primary renal neoplasms.
Untreated DMH positive DMH with
control control amosite
M F M F M F
Animals examined 117 117 125 124 173 175
Total renal tumorsa 0(0) 1(1) 3(2) 49(32)* 4(2) 56(32)*
aValues in parentheses are percentages.
*p= <0.01.
A significantly increased incidence of neoplas-
tic nodules and/or hepatocellular carcinomas oc-
curred in groups receiving DMH alone and in
groups receiving DMH plus amosite. Generally,
females had a higher incidence (p < 0.01) than
males (p < 0.05).
Miscellaneous Neoplasms
In several instances, DMH treatment with or
without amosite led to statistically significant
decreased incidences ofcertain spontaneous neo-
plasms, particularly of the endocrine system.
39Table 16. Number ofDMH-exposed F344 rats with Zymbal gland neoplasms.
Untreated DMH positive DMH with
control control amosite
M F M F M F
Animals examined 117 117 125 124 173 175
Zymbal gland
neoplasmsa 1(1) 4(3) 33(26)* 34(27)* 55(32)* 39(22)*
aValues in parentheses are percentages.
*p < 0.01 vs. controls.
Tble 17. Number ofDMH-exposed F344 rats with hepatocellular neoplasms.
Untreated DMH positive DMH with
control control amosite
M F M F M F
Animals examined 117 117 125 124 173 175
Neoplastic nodulesa 9(8) 4(3) 18(14)* 29(23)* 27(15)* 32(18)*
Hepatocellular carcinomaa 1(1) 1(1) 9(7)* 10(8)* 7(4)t 8(5)t
aValues in parentheses are percentages.
*p < 0.05 vs. controls.
tp < 0.05 vs. controls (incidental tumor and life table analysis).
tp < 0.05 vs. controls (life table analysis only).
These included a reduced number of subcutane-
ous fibromas, pituitary adenomas in females, ad-
renal pheochromocytomas, pancreatic acinar cell
adenomas and islet cell adenoma in males, mam-
mary tumors, and interstitial cell tumors in male
rats. However, many animals in these two groups
died at an early age compared to the untreated
controls.
Discussion
Tremolite (11) or amosite asbestos (12) was
administered at a level of 1% in the diet to male
and female F344 rats for their lifetime, including
exposure oftheirdams to the test material. While
the tremolite used in this study is considered
crystalline or nonfibrous in its natural form, a
small amount assumes a fibrous character during
the crushing and milling process. However, the
milling process used in the preparation of the
tremolite for this study was identical to what is
done in the commercial setting.
Starting atbirth, oneofthree groups ofneonate
rats from amosite-exposed mothers were given
chrysotile asbestos (instead ofamosite) by gavage
until weaning at which time they were given the
1% amosite diet. For all intents and purposes this
group ofrats shouldbe regarded as beingexposed
to amosite asbestos for their lifetime. Two groups
(control and amosite exposed) of weanling rats
were exposed to five biweekly doses of 1,2-di-
methylhydrazine dihydrochloride (DMH), a
known intestinal carcinogen, to testthe promotor
or cocarcinogenic effects of DMH and amosite
asbestos.
The clinicopathologic results in this study
showed that the ingestion oftremolite or amosite
asbestos did not adversely affect the fertility of
the mothers or litter size of the F1 bioassay ani-
mals. The average weight ofthe offspring atbirth
from mothers exposed to either mineral was com-
parable to the offspring of nonexposed mothers.
However, the weight of the exposed offspring at
weaning was slightly less than the control rats.
The cause ofthe decreases in weight during lacta-
tion is not known. The differences in body weight
gain became more apparant between weaning
and 8 weeks of age. While the tremolite- and
amosite asbestos-exposed rats paralleled the con-
trol animals in weight gain, they remained
smaller throughout their life. The mean body
weight ofthe male rats exposed to the chrysotile
preweaning gavage (PWG) and subsequently to
amosite asbestos was slightly higher than the
amosite alone rats. This may be related to the
mortality induced in the neonates by the PWG
technique which would allow the remaining pups
more milk during lactation. Exposure to DMH
caused a small reduction in body weight gain in
female but not in male rats.
No clinical signs were observed which could be
attributed to the ingestion of either mineral.
Starting at 9 months of age, the DMH-exposed
rats showed signs attributable to DMH-related
neoplasia, but no difference was noted between
the DMH and DMH plus amosite groups.
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The ingestion of either tremolite or amosite in
the diet for the life of the rats did not adversely
affect their survival. In fact, survival of female
rats exposed to amosite or amosite plus chrysotile
PWGwas slightlybetterupto 112 weeksthanthe
controls. Similarly, the survival of male rats ex-
posed to amosite was slightly better than the
untreated controls, although the amosite plus
chrysotile PWG group showed slightly less sur-
vivability.
The most plausible explanation for the in-
creased survival of the amosite exposed rats is
their lower weightthroughout the study. Yu et al.
(13) have shown that rats of lower body weight
caused by restricted caloric intake lived longer
than rats that were allowed to eat an unlimited
amount offood.
The survival ofthe rats (control and amosite) in
this study compares favorably with other NTP
bioassays (14). At 106 weeks ofage (age at end of
typical 2-yr bioassay) the percentage ofmale rats
alive in this study was: untreated tremolite con-
trol, 83%; untreated amosite control, 81%; tremo-
lite, 82%; amosite, 88%; and amosite plus PWG,
77%. The percentage of female rats alive at this
time was: tremolite control, 82%; amosite control,
79%; tremolite, 84%; amosite, 82%; and amosite
plus PWG, 86%. Haseman (14) in reviewing the
25 most recent NTP feeding studies found an
average of 66% of control males and 73% of con-
trol females alive at 112 weeks ofage.
The survival of control groups of males and
females was similar at 106 weeks. In most 2-yr
studies involving rats, more females generally
survive to the end of the study than do males.
However, the longer survival offemale rats (con-
trol and tremolite or amosite exposed) was clearly
demonstrated after 142 weeks.
The ingestion of either tremolite or amosite
asbestos over the lifetime of these rats did not
cause a biologically significant increase of neo-
plasms at any anatomic site when compared to
the concurrent controls. The gastrointestinal
tract was considered a potential target organ
based on epidemiological studies in humans (15).
The overall incidence of intestinal neoplasms in
the control (male 4 and female 2%) and two amo-
site asbestos groups (male 3 and female 2%; male
4 and female 3%) was low, and there was no
significant (p < 0.05) difference between the
treated and control groups. Similar observations
were noted in the tremolite groups and their
respective controls. In addition, nonneoplastic le-
sions of the gastrointestinal tract were not in-
creased. In summary, amosite asbestos did not
cause any adverse affects in the gastrointestinal
tract ofeither male or female F344 rats.
Rats exposed to DMH showed a high incidence
(60-70%) of neoplasia of the gastrointestinal
tract, primarily in the large intestine. This high
rate of intestinal neoplasia was unexpected be-
cause a pilot study (3) using the same dosing
regimen of DMH would have predicted an inci-
dence of15 + 5% inthis study. In aprevious NTP
bioassay, hamsters exposed to DMH and chryso-
tile asbestos also failedto developthe desiredrate
ofintestinal tumors basedon a similarpilot study
(28). Apparently the neoplastic dose response to
DMH is relatively steep and duplication of low
rates ofintestinal neoplasia are difficult to repro-
duce.
Because ofthe high background rate of DMH-
induced neoplasia, it is not possible to determine
with accuracy if amosite had a cocarcinogenic or
additive effect in this study. Female rats exposed
to DMH and amosite had a higher incidence (11%
versus 2%) ofneoplasia ofthe duodenum than the
DMH controls. Conversely, they had a lower inci-
dence (9% versus 1%) of neoplasms of the jeju-
num; thus the total number ofanimals with neo-
plasms ofthe small intestine was comparable. A
similar situation was observed in the large intes-
tine ofmale rats. The rats exposed to DMH alone
had a higher incidence (13% versus 3%) ofcarci-
noma of the cecum but a lower incidence (13%
versus 26%) ofneoplasms ofthe transverse colon.
The morphologic appearance of the neoplasms
induced by DMH were comparable to those de-
scribed previously in rats exposed to hydrazine
compounds (16). In addition, the few intestinal
neoplasms which occurred in the control and tre-
molite- or amosite (no DMH)-exposed rats were of
the same morphologic types to those induced by
DMH. The neoplasms observed in the kidney,
liver and Zymbal's gland of DMH-exposed rats
were consistent with those reported for these
types ofintestinal carcinogens (17).
A significantly (p < 0.05) increased incidence of
C-cell carcinomas ofthe thyroid occurred in amo-
site-treated male rats. This effect was not ob-
served in the amosite PWG male rats and the
overall incidence of total benign and malignant
C-cell tumors was comparable between control
and treated groups. Therefore, this is not consid-
ered to be a treatment-related effect.
The incidence of mononuclear cell leukemia
(synonyms-monocytic leukemia, Fisher rat leu-
kemia) was elevated in amosite (42%) and amo-
site PWG (49%) male rats compared to the con-
current control group (32%). However, the rates
were not significant when compared to the tremo-
lite male control group (39%). This increased inci-
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dence was not observed in treated female rats.
Coleman et al. (18) reported an incidence of
nearly 30% in male F344 rats within the age
group of 24 40 months. In 2-yr-old F344 rats,
Goodman et al. (19) reported 12% of males and
nearly 10% offemales hadlymphoma/leukemia, a
much lower incidence than in these studies. It is
apparent from this study and above cited studies
that the incidence of leukemia increases rapidly
after 2 years ofage. In view ofconsiderable varia-
tion in the incidence of such disorders, the fact
that the amosite-exposed male rats survived
longer than their concurrent controls and lack of
significance when compared to the tremolite con-
trol group, it is doubtful that the increase in the
rate of leukemia is treatment related. More im-
portantly, an increased incidence of neoplasia
was not observed in target organs (GI tract and
mesothelium). Even though it is known that cer-
taintypes ofasbestos are absorbedthroughthe GI
tract (20,21), it is difficult to envision how oral
asbestos could cause an increase in leukemia
without causing an increase of tumors in the
proposed target tissues.
In summary, these effects represent only amod-
ulation of neoplasms which occur in concurrent
control groups and are known to occur in histori-
cal control rats of this strain. No uncommon or
unique neoplasms were observed in any of the
tremolite- or amosite-treated groups. In addition,
the biological importance ofthe neoplasms in the
absence oftarget organ neoplasia is questionable.
A large variety of nonneoplastic lesions, pri-
marily lesions of aging, were observed in all
groups. There wasno obvious correlation between
treatment and specific lesions. Therefore, tremo-
lite or amosite at the level of 1% in the diet did
not appear to cause any overt toxicity.
Studies on the effects of chronic ingestion of
tremolite are not available. However, Stanton et
al. (2) showed that the intrapleural inoculation of
fibrous tremolite (two types) caused a high inci-
dence ofpleural sarcoma in Osborne-Mendel rats.
In contrast, intrapleural studies oftremolite talc
failed to show a carcinogenic response in ham-
sters (22). The tremolite used in the NTP study is
anonfibrous type and moreclosely resemblesthat
used by Smith (22) than Stanton et al. (2).
Other studies involving the long-term inges-
tion of asbestos are few. Donham et al. (23) re-
ported equivocal results in F344 rats which were
fed a diet containing 10% chrysotile for their
lifetime. Whilethey did not observe astatistically
significant (p < 0.05) increase in the number of
tumors in exposed animals, the authors believed
that there was a trend toward increased colon
lesions in general, evidence ofpenetration of as-
bestos into the colonic mucosa, possible cytotoxic-
ity to colonic tissues and suggested a possible
relationship to peritoneal mesothelioma. Another
equivocal study is that reported by Gibel et al.
(24), who described an increase in malignant tu-
mors in the lung, kidney, liver and reticuloen-
dothelial system but no increase in intestinal
neoplasia in Wistar rats fed asbestos filter mate-
rial (20 mg/day) for a period of 8-14 months.
Cunningham et al. (25) reported two studies in
Wistar male rats using 1% chrysotile in the diet:
one study of 24 months and one of 30 months.
These authors concluded that trace amounts of
ingested asbestos can penetrate the walls of the
gastrointestinal tract, but evidence of carcinoge-
nicity was inconclusive. Negative results were
reported by Gross et al. (26), who fed rats a diet
containing 5% chrysotile asbestos for a period of
21 months with no evidence ofintestinal neopla-
sia.
Corollary studies to this investigation were
conductedin Syrian goldenhamsters (27,28). The
exposure regimen was similar in that male and
female hamsters were exposed to 1% amosite as-
bestos (same source as the subject study) and
short-range or intermediate-range chrysotile as-
bestos in their diet for their natural life-span.
There was no adverse effect on body weight gain
or survival, and no asbestos-related neoplasms
were observed.
Another oral asbestos study in hamsters was
reported by Smith et al. (29). They exposed
groups of30 male and female hamsters via drink-
ing water for lifetime to amosite asbestos, mine
tailings, beach rock or Lake Superior drinking
water. They did not observe adverse effects on
bodyweight orsurvival time in any ofthe groups.
A peritoneal mesothelioma, one pulmonary carci-
noma, and two early squamous cell carcinomas of
the nonglandular stomach were found in the
hamsters exposed to amosite but the incidence
was not statistically significant (p < 0.05). They
concluded that the study was essentially nega-
tive. A subsequent study in rats using similar
materials also failed to elicit a carcinogenic re-
sponse (30).
Except for the studies of Donham et al. (23),
Smith et al. (29) and the NTP (11, 12,27, 28), the
other studies were conducted with relatively
small numbers of animals. Also some were con-
ducted for an insufficient period of time to ade-
quatelytestthecarcinogenicpotential ofingested
asbestos.
A long-term study ofamosite asbestos designed
to determine the promotor potential of asbestos
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was reported by Ward et al. (31). They exposed 6-
week-old male F344 rats three times per week for
10 weeks to 1 mg amosite asbestos in saline via
gavage. Once per week during this same period,
half of the rats received subcutaneous injections
of 7.4 mg/kg azoxymethane (AOM), a known in-
testinal carcinogen in animals which produces
effects similar to DMH. The rats were allowed to
live out their lifespan or untl 94-95 weeks ofage
at which time they were killed. The authors re-
ported an intestinal tumor incidence of 66.7% in
AOM alone, 77.1% for amosite plus AOM and
32.6% for amosite alone. The authors concluded
that while amosite didnot significantly add to the
incidence of AOM-induced intestinal neoplasia,
amosite alone caused a relatively high rate of
intestinal neoplasia. However, there was no un-
treated control group to compare to the treated
groups. These results should also be viewed with
some suspicion because the authors also reported
a 14% incidence of Zymbal gland tumors in the
rats exposed to amosite alone. The historical rate
ofZymbal gland tumors in the Bioassay Program
is 0.34%, indicating that this is a relatively rare
tumor (19). However, AOM is known to induce
Zymbal gland tumors with a sngle dose of5.1 mg/
kg in male F344 rats producing a 14% incidence
oftumors in this organ (17); in this study 5.1 mg/
kg AOM also caused a 24% incidence ofintestinal
neoplasia. A possible explanation for the inci-
dence of Zymbal gland tumors in the amosite
groups would be that they were inadvertently
exposed to AOM. If this occurred, these rats
wouldalsobe expected to show ahigh incidence of
intestinal neoplasms.
Conclusions
Under the conditions of this lifetime bioassay,
tremolite or amosite asbestos was not toxic, did
not affect survival, and was not carcinogenic
when ingested at a level of1% in the dietby male
and female Fischer 344 rats. While there were
significant (p > 0.05) increases in the rate of C-
cell carcinomas ofthe thyroid in male, and mono-
cytic (mononuclear cell) leukemia in male rats
exposed to amosite asbestos compared to un-
treated controls, their biological significance is
questionable because of a lack ofresponse in the
concurrent amosite and preweaning gavage
group or control group of the corollary study,
nonaffect when all neoplasms of that organ are
analyzed, lack ofsignificance when examined us-
ing life table analysis or the absence ofneoplasia
in target organs. The cocarcinogenic studies us-
ing 1,2-dimethylhydrazine dihydrochloride
(DMH) were considered flawed because of the
high rate ofintestinal carcinogenesis in both the
DMH and amosite asbestos and DMH alone
groups.
The animal phase ofthis study was performed at Hazleton
Laboratories America, Vienna, VA. This project has been
funded with federal funds from the National Institute of
Environmental Health Sciences (NIH), Research Thiangle
Park, NC, under contract #5-2158. Partial funding was pro-
vided by the Environmental Protection Agency under Intera-
gency Agreement #D70756.
The research described in this paper has been peer and
administratively reviewed by the U.S. Environmental Protec-
tion Agency and approved for presentation and publication.
Mention of trade names or commercial products does not
constitute endorsement or recommendation for use.
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